Search Within
SRP3178
Applied Filters:
Keyword:'SRP3178'
Showing 1-10 of 10 results for "SRP3178" within Papers
Kuter, D.J., et al.
Cytokine Reference, 965-982 (2001)
Monique Bethel et al.
Journal of cellular physiology, 230(9), 2142-2151 (2015-02-07)
Emerging data suggest that megakaryocytes (MKs) play a significant role in skeletal homeostasis. Indeed, osteosclerosis observed in several MK-related disorders may be a result of increased numbers of MKs. In support of this idea, we have previously demonstrated that MKs
Krasimira Rozenova et al.
Blood, 125(11), 1730-1738 (2015-02-01)
Hematopoietic stem cell (HSC) self-renewal and multilineage reconstitution are controlled by positive and negative signaling cues with perturbations leading to disease. Lnk is an essential signaling adaptor protein that dampens signaling by the cytokine thrombopoietin (Tpo) to limit HSC expansion.
Jiaxin Zhao et al.
Arteriosclerosis, thrombosis, and vascular biology, 41(10), 2523-2537 (2021-08-06)
Objective: Roxadustat is a new medication for the treatment of renal anemia. EPO (erythropoietin)-the current treatment standard-has been reported to enhance platelet activation and production. However, to date, the effect of roxadustat on platelets is unclear. To address this deficiency
Majed J Dasouki et al.
Blood, 122(20), 3440-3449 (2013-10-03)
We recently identified 2 siblings afflicted with idiopathic, autosomal recessive aplastic anemia. Whole-exome sequencing identified a novel homozygous missense mutation in thrombopoietin (THPO, c.112C>T) in both affected siblings. This mutation encodes an arginine to cysteine substitution at residue 38 or
T A Blair et al.
Journal of thrombosis and haemostasis : JTH, 13(8), 1479-1493 (2015-06-04)
Aspirin and P2Y12 antagonists are antiplatelet compounds that are used clinically in patients with thrombosis. However, some patients are 'resistant' to antiplatelet therapy, which increases their risk of developing acute coronary syndromes. These patients often present with an underlying condition
Christopher R Burtner et al.
Human gene therapy, 26(6), 399-406 (2015-04-29)
Most hematopoietic stem cell gene therapy studies require host conditioning to allow for efficient engraftment of gene-modified cells. Conditioning regimens with lower treatment-related toxicities are especially relevant for the treatment of nonmalignant blood disorders, such as hemoglobinopathies and immunodeficiencies, and
Pancreatic Cancer Cells Induce MicroRNA Deregulation in Platelets.
D?-az-Blancas, et al.
International Journal of Molecular Sciences, 23 (2022)
The molecular mechanisms that control thrombopoiesis.
Kaushansky K
The Journal of Clinical Investigation, 115(12), 3339-3347 (2005)
Yoshio Takei
Handbook of Hormones: Comparative Endocrinology for Basic and Clinical Research (2015)
Page 1 of 1